⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

INMB News

INmune Bio Inc. Common stock

INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal